March 30, 2012
WALTHAM, Mass.– At the American Association for Cancer Research 2012 Annual Meeting (Booth #2306), PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it will be showcasing numerous solutions, posters and knowledge-sharing events in support of cancer-focused personalized medicine research. "PerkinElmer remains committed to [...]
Perten Headquarters Relocates to Larger Building
March 30, 2012
Perten Instruments headquarters in Stockholm, Sweden has moved to larger offices. Göran Sandén – Head of Global After-Market – states “We’ve added 11 new service, applications specialists, and engineers in the last two years. We were bursting at the seams in our old building. The new offices allow us to continue our growth in after-sales [...]
March 30, 2012
Austin, Texas – Asuragen, Inc. announced today that the Company received notice of a $6.8 million commercialization award to pursue Next Generation Sequencing (NGS) applications from the State of Texas through the Cancer Prevention and Research Institute of Texas (“CPRIT”). CPRIT was established to expedite innovation and commercialization in the area of cancer research and [...]
March 30, 2012
OMAHA, Neb.,– Transgenomic, Inc. today announced that Jeana DaRe, Ph.D., Assistant CLIA Laboratory Director at Transgenomic, presented clinical findings from patients tested for nuclear mitochondrial disorders using Transgenomic’s NuclearMitome Test on Thursday, March 29, at the 2012 Annual Meeting of the American College of Medical Genetics (ACMG) in Charlotte, North Carolina. The discussion, titled “Clinical [...]
March 30, 2012
SAN DIEGO, CA — Genalyte, Inc., a life sciences company developing and commercializing innovative next-generation multiplexing technology, today announced completion of an $11.8 million Series B financing. New investors Redmile Group and Claremont Creek Ventures and private investors from Genalyte’s Series A round participated in the Series B financing. Genalyte intends to use the new [...]
Abbott’s PLEX-ID Molecular System and Tests for Broad Microbial Identification Obtain CE Marking
March 30, 2012
Wiesbaden, Germany — Abbott announced today it has obtained CE Marking (Conformité Européene) in the European Union to market its rapid, high-throughput PLEX-ID™ instrument, along with three assays for use on the system: PLEX-ID Viral IC Spectrum, PLEX-ID BAC Spectrum BC and PLEX-ID Flu. PLEX-ID, which is based on molecular diagnostic technologies, addresses a significant [...]
March 30, 2012
PLEASANTON, Calif.,- Roche announced today the FDA approval of a new pre-analytical instrument that provides an integrated primary tube handling solution for its widely adopted automated molecular testing platform. The cobas p 630 Instrument, being introduced with new AMPLILINK 3.3 series software, unites primary tube handling with fully automated sample preparation, amplification and detection for [...]
FDA Detectives use Stomacher® 400 circulator for sample preparation in cantaloupe Listeriosis scare
March 29, 2012
Worthing, UK – Seward, the manufacturer and developer of the patented Stomacher® Paddle Blender range, highlights the use of the Stomacher® 400 Circulator in the elimination of soil and fruit as possible sources in a recent fatal cantaloupe melon Listeriosis scare. At the height of the scare the outbreak detectives of the FDA were mystified [...]
Almac and Affymetrix Announce a Global Distribution Agreement for Almac’s Xcel™ Array
March 29, 2012
Almac today announced that it has signed an exclusive global distribution deal with Affymetrix, Inc. enabling them to directly sell Almac’s proprietary Xcel™ array for biomarker discovery, development and delivery worldwide. Almac’s Xcel™ array is a high density transcriptome-based microarray that has been optimised for the discovery and development of biomarkers from formalin fixed paraffin [...]
GenMark Enters into License Agreement with PerkinElmer for Microfluidics Patent Portfolio
March 29, 2012
CARLSBAD, Calif.-- GenMark Diagnostics, Inc., announced today that it has entered into a license agreement with PerkinElmer, granting GenMark a non-exclusive license under PerkinElmer's microfluidics patent portfolio. "Completing this agreement strengthens GenMark's patent portfolio and provides us with maximum flexibility as we expand our menu of high-value multiplex molecular tests and develop new innovative platforms [...]
